+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
From
From
From
From
Tuberculosis Treatment Drugs Companies in China - Product Thumbnail Image

Tuberculosis Treatment Drugs Companies in China

  • Report
  • September 2024
  • 69 Pages
  • China
From
Respiratory Drugs Companies in China - Product Thumbnail Image

Respiratory Drugs Companies in China

  • Report
  • September 2024
  • 51 Pages
  • China
From
Respiratory Drugs Markets in China - Product Thumbnail Image

Respiratory Drugs Markets in China

  • Report
  • September 2024
  • 213 Pages
  • China
From
Tuberculosis Treatment Drugs Markets in China - Product Thumbnail Image

Tuberculosis Treatment Drugs Markets in China

  • Report
  • September 2024
  • 227 Pages
  • China
From
Respiratory Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Respiratory Drugs Industry Forecasts - China Focus

  • Report
  • September 2024
  • 116 Pages
  • China
From
Asthma Treatment Drugs Companies in China - Product Thumbnail Image

Asthma Treatment Drugs Companies in China

  • Report
  • August 2024
  • 133 Pages
  • China
From
Asthma Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Asthma Treatment Drugs Industry Forecasts - China Focus

  • Report
  • August 2024
  • 101 Pages
  • China
From
Pneumonia Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Pneumonia Treatment Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 110 Pages
  • China
From
From
Xopenex - API Insight, 2022 - Product Thumbnail Image

Xopenex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Singulair Paediatric - API Insight, 2022 - Product Thumbnail Image

Singulair Paediatric - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Mucodyne - API Insight, 2022 - Product Thumbnail Image

Mucodyne - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Fumarate De Formoterol - API Insight, 2022 - Product Thumbnail Image

Fumarate De Formoterol - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Rocephin - API Insight, 2022 - Product Thumbnail Image

Rocephin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more